Die genetische Testung ist der Myokardbiopsie bei Kardiomyopathien überlegen – contra

Schlüsselwörter

hypertrophe Kardiomyopathie (HCM) - dilatative Kardiomyopathie (DCM) - arrhythmogene rechtsven- trikuläre Kardiomyopathie (ARVC)

Keywords

hypertrophic cardiomyopathy - dilated cardiomyopathy - arrhythmogenic right ventricular cardiomyopathy

• Literatur

• 1 Ackermann MJ et al. HSR/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace 2011; 13: 1077-1109
• 2 Andreasen C et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Euro J Hum Genet 2013; doi:
• 3 Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009; 30: 1995-2002
• 4 Kuehl U et al. Interferon-beta- improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol 2012; 60: 1295-1296
• 5 Schultheiss HP, Kuehl U, Cooper LT. The management of myocarditis. Eur Heart J 2011; 32: 2616-2665
• 6 van der Zwaag PA, van Tintelen JP. Counsel the genotype, treat the phenotype. Europ J Heart Failure 2011; 13: 1159-1160